93 related articles for article (PubMed ID: 17347973)
1. Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephrotic syndrome.
Kawasaki Y; Takano K; Isome M; Suzuki J; Suyama K; Kanno H; Fujiki T; Suzuki H; Hosoya M
J Nephrol; 2007; 20(1):52-6. PubMed ID: 17347973
[TBL] [Abstract][Full Text] [Related]
2. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Okada S; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[TBL] [Abstract][Full Text] [Related]
3. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Kawasaki Y; Hosoya M; Kobayashi S; Ohara S; Onishi N; Takahashi A; Isome M; Suzuki H
Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Utsunomiya Y; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2008 Mar; 69(3):179-84. PubMed ID: 18397716
[TBL] [Abstract][Full Text] [Related]
5. Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.
Kawasaki Y; Suzuki J; Takahashi A; Isome M; Nozawa R; Suzuki H
Pediatr Nephrol; 2005 Jan; 20(1):96-8. PubMed ID: 15503173
[TBL] [Abstract][Full Text] [Related]
6. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome.
Yoshioka K; Ohashi Y; Sakai T; Ito H; Yoshikawa N; Nakamura H; Tanizawa T; Wada H; Maki S
Kidney Int; 2000 Jul; 58(1):317-24. PubMed ID: 10886577
[TBL] [Abstract][Full Text] [Related]
7. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
8. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Goto M; Ikeda M; Hataya H; Ishikura K; Hamasaki Y; Honda M
Nihon Jinzo Gakkai Shi; 2006; 48(4):365-70. PubMed ID: 16780106
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine: a new approach in the treatment of renal disease.
Kawasaki Y
Clin Dev Immunol; 2009; 2009():681482. PubMed ID: 20052390
[TBL] [Abstract][Full Text] [Related]
10. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
Miyamae T; Nakasima S; Imagawa T; Ito S; Katakura S; Tomono N; Mori M; Ibe M; Mitsuda T; Aihara Y; Yokota S
Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.
Mima A
Rheumatol Int; 2017 Aug; 37(8):1387-1393. PubMed ID: 28255645
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
13. Oral mizoribine pulse therapy for steroid-dependent focal segmental glomerulosclerosis.
Doi T; Masaki T; Shiraki N; Kawai T; Yorioka N
Clin Nephrol; 2008 Jun; 69(6):433-5. PubMed ID: 18538119
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.
Imaizumi T; Kawasaki Y; Matsuura H; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Aug; 22(8):1215-8. PubMed ID: 17347835
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
Tanaka Y; Yoshikawa N; Hattori S; Sasaki S; Ando T; Ikeda M; Honda M;
Pediatr Nephrol; 2010 May; 25(5):877-82. PubMed ID: 19902267
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
17. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Onuma S; Kimura S; Ito E
Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
[TBL] [Abstract][Full Text] [Related]
18. Mizoribine in steroid-dependent nephrotic syndrome of childhood.
Hamasaki T; Mori M; Kinoshita Y; Saeki T; Sakano T
Pediatr Nephrol; 1997 Oct; 11(5):625-7. PubMed ID: 9323293
[TBL] [Abstract][Full Text] [Related]
19. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Ohtomo Y; Fujinaga S; Takada M; Murakami H; Akashi S; Shimizu T; Kaneko K; Yamashiro Y
Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
Nishi E; Kameda H; Ogawa H; Nagasawa H; Takei H; Okuyama A; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Sakai R; Ito T; Takeuchi T; Amano K
Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
